Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2002
11/21/2002US20020170125 Bridged diaminopyrazole compounds and dye compositions containing same
11/21/2002DE10125294A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002DE10125293A1 New anthranilamide derivatives and analogs containing heterocycle N-oxide group, as KDR/FLT tyrosine kinase inhibitors, used for e.g. treating psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446797A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002EP1257550A1 Platelet adp receptor inhibitors
11/20/2002EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002EP0920427B1 Process for the preparation of benzopyran compounds
11/20/2002EP0837853B1 Substituted cyanophenyl uracils
11/20/2002EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002CN1380882A C10 ester substituted taxanes as antitumor agents
11/20/2002CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/19/2002US6482962 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative
11/19/2002US6482956 Endothelin receptor antagonists
11/19/2002US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002US6482841 Pyridyl compounds and pharmaceutical compositions containing them
11/19/2002US6482838 Cholinesterase inhibitor
11/19/2002US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002US6482827 Matrix metalloproteinase inhibitors
11/19/2002US6482826 Method of treating alopecia
11/19/2002US6482773 Pyridazin-3-one derivatives, their use, and intermediates for their production
11/19/2002CA2072162C Diastereomer salt of optically active quinolinemevalonic acid
11/18/2002WO2001087855A1 Triazole derivatives
11/15/2002WO2001087875A1 Novel benzofuran derivatives
11/15/2002CA2409096A1 Novel benzofuran derivatives
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090354A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002WO2002090342A1 Chromene compound
11/14/2002WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002WO2002090314A1 Pyruvate derivatives
11/14/2002WO2002089810A1 Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089782A2 Dioxanes and uses thereof
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002068417A3 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/14/2002WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/14/2002WO2002055014A3 Therapeutic chroman compounds
11/14/2002WO2002055013A3 Therapeutic chromone compounds
11/14/2002WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002WO2001020995A9 Compounds directed against pilus biogenesis and activity in pathogenic bacteria; methods and compositions for synthesis thereof
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169323 Selective serotonin reuptake inhibitor; antidepressant, anti-Parkinson agent
11/14/2002US20020169322 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
11/14/2002US20020169188 Modulating neurotransmission in the central nervous system
11/14/2002US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002US20020169182 Neurotrophin antagonist compositions
11/14/2002US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002US20020169171 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
11/14/2002US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002DE10122603A1 New 1-amidocarbonylmethyl-piperidine derivatives, useful for treating gastrointestinal motility disorders and gastro-esophageal reflux, are motilin agonists
11/14/2002CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002CA2446396A1 N-aroyl cyclic amines
11/14/2002CA2446365A1 Sulfonamides
11/14/2002CA2446051A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002EP1255740A2 Substituted arylpyrazines
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1255737A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole
11/13/2002EP1255735A2 Pyridine derivatives as potentiators of glutamate receptors
11/13/2002EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002EP0950057B1 3-pyridyl enantiomers and their use as analgesics
11/13/2002EP0949921B1 Thrombin inhibitors
11/13/2002EP0912515B1 1,4-di-substituted piperidines as muscarinic antagonists
11/13/2002EP0811603B1 Aminotetralone derivatives and process for producing the same
11/13/2002CN1379774A Compounds
11/13/2002CN1379773A Novel isoquinoline derivatives or salts thereof
11/13/2002CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002CN1379764A Benzodiazepine derivatives
1 ... 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 ... 694